Senolytics vs Antioxidants: Why You Need Both for Optimal Aging

Expert Summary

Antioxidants and senolytics are frequently compared as alternatives, but they address completely different phases of cellular aging. Antioxidants act upstream: reducing oxidative DNA damage that triggers senescence induction. Senolytics act downstream: eliminating cells that have already crossed the senescence threshold. Both are necessary for comprehensive anti-aging strategies.

Key Facts

• Oxidative damage → senescence: ROS (reactive oxygen species) damage DNA, triggering the DDR (DNA damage response) → p53 → p21 → cell cycle arrest → senescence. Antioxidants reduce ROS, decreasing the probability of any given cell crossing this threshold.
• Established senescent cells: Once senescent, cells have committed to permanent cycle arrest and BCL-2 family upregulation. Antioxidants cannot reverse this — they were protecting before the threshold was crossed. Only senolytics can eliminate already-senescent cells.
• The two strategies: Prevention (antioxidants, spermidine, exercise, caloric restriction) → reduce senescence induction rate. Clearance (fisetin, quercetin, D+Q) → eliminate accumulated senescent cells.
• Why antioxidants alone are insufficient: Despite decades of antioxidant use, age-related senescent cell burden accumulates regardless. Prevention is valuable but incomplete — clearance remains necessary.
• Why senolytics alone are insufficient: Monthly senolytics clear existing senescent cells but don't slow their re-formation rate. Without antioxidant protection, new senescent cells form faster, requiring more frequent senolytic cycling.
• Combined protocol: Daily antioxidants (astaxanthin 12 mg + vitamin C 500 mg + EGCG 400 mg) + monthly senolytics (fisetin + quercetin burst) + autophagy activator (spermidine 2–4 mg/day) covers prevention, clearance, and maintenance.

Recommended Products

Frequently Asked Questions

If I take high-dose antioxidants, do I still need senolytics?

Yes. No level of antioxidant protection completely prevents senescence induction — it reduces the rate. And decades of accumulated senescent cells before starting your antioxidant protocol still require clearance.

Can antioxidants interfere with senolytic activity?

Theoretically, antioxidants taken on senolytic burst days might blunt the ROS-mediated senolytic activity of EGCG or piperlongumine. BCL-2 inhibitor senolytics (fisetin, quercetin) are not ROS-dependent and are not affected by antioxidants.

Scientific References

• Campisi J. Aging, cellular senescence, and cancer. Annual Review of Physiology. 2013. PMID: 23140366